Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
基本信息
- 批准号:8463209
- 负责人:
- 金额:$ 30.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-15 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Type IV P-type ATPases (P4-ATPases) are a large family of putative phospholipid translocases, or flippases, implicated in the generation and maintenance of phospholipid asymmetry in biological membranes. It is thought that P4-ATPases directly pump specific lipid substrates, such as phosphatidylserine (PS) and phosphatidylethanolamine (PE), from the extracellular leaflet to the cytosolic leaflet of a membrane to produce asymmetry. The medical significance of an asymmetric plasma membrane is best understood in blood cells where regulated exposure of phosphatidylserine (PS) on the extracellular leaflet induces blood clotting. In addition, cells undergoing programmed cell death also expose PS on the extracellular leaflet facilitating their recognition and phagocytosis by other cells. Thus, normal establishment and regulation of membrane phospholipid asymmetry plays a critical role in prevention of cardiovascular disease and in tissue remodeling during development and wound repair. Moreover, deficiency of a human P4-ATPase (Atp8b1) causes familial intrahepatic cholestasis, a disease where loss of PS asymmetry in the bile canalicular membrane leads to damage of this membrane by secreted bile, ultimately leading to liver failure. P4-ATPase deficiency in mice is linked to diet induced obesity and type 2 diabetes (Atp10a and Atp10d) as well as decreased male fertility (Atp8b3). Characterization of P4-ATPases in the budding yeast Saccharomyces cerevisiae (Drs2, Neo1, Dnf1, Dnf2 and Dnf3) has allowed the application of powerful molecular genetic tools to dissect the biochemical and cell biological functions of these potential flippases. In addition to supporting the proposed function in generating membrane asymmetry, these studies have surprisingly shown that P4-ATPases are required for vesicle-mediated protein transport in the secretory and endocytic pathways. Drs2 localizes to the trans-Golgi network (TGN) and is required to bud AP-1/clathrin-coated vesicles from this organelle by a mechanism that is independent of clathrin coat recruitment to the membrane. It is hypothesized that Drs2 directly pumps phospholipid substrates across the TGN membrane to induce membrane curvature that is captured and molded by clathrin into a vesicle. The proposed studies will determine for the first time if a P4-ATPase (Drs2) is sufficient in a purified form to directly catalyze phospholipid flippase activity in proteoliposomes. The native substrate preference will be determined in the reconstituted system as well as the contribution of the noncatalytic subunit (Cdc50) to flippase activity. The influence of Drs2 activity on membrane curvature and vesicle formation with proteoliposomes and isolated TGN membranes will be tested. In addition, preliminary studies indicate that Drs2 is a novel effector of important molecules controlling vesicle budding from the TGN (phosphatidylinositol 4-phosphate, ArfGEF, Kes1) and the mechanistic basis for this regulation will be determined.
描述(由申请人提供):IV型P型ATPases(P4-ATPases)是一个大型推定的磷脂易位酶,或Flippases,涉及生物膜中磷脂不对称的生成和维持。人们认为,P4-ATPase将特异性脂质底物(例如磷脂酰甲酯(PS)和磷脂酰乙醇胺(PE))从细胞外叶片到膜的细胞叶片产生不对称性。在血细胞中最好理解不对称质膜的医学意义,在血液细胞中,调节磷脂酰丝氨酸(PS)在细胞外叶片上的暴露会诱导血液凝结。此外,经历了程序性细胞死亡的细胞还暴露于细胞外小叶上的PS,从而促进了其他细胞的识别和吞噬作用。因此,膜磷脂不对称的正常建立和调节在预防心血管疾病和在发育和伤口修复过程中的组织重塑中起着至关重要的作用。此外,人P4-ATPase(ATP8B1)的缺乏会导致家族性肝内胆汁淤积,这种疾病是胆管膜中PS不对称性的损失导致分泌的胆汁损害该膜,最终导致肝衰竭。小鼠的P4-ATPase缺乏与饮食诱导的肥胖症和2型糖尿病(ATP10A和ATP10D)以及男性生育能力降低有关(ATP8B3)。在酿酒酵母的出现酵母糖酵母中的P4-ATP酶(DRS2,NEO1,DNF1,DNF2和DNF3)允许应用强大的分子遗传工具来解剖这些潜在弹药的生物化学和细胞生物学功能。除了支持产生膜不对称性的拟议功能外,这些研究令人惊讶地表明,在分泌和内吞途径中,囊泡介导的蛋白转运需要P4-ATPases。 DRS2定位于反式高尔基网络(TGN),是通过一种独立于网状蛋白外套募集到膜的机制来从该细胞器中从该细胞器中芽的AP-1/胶蛋白涂层的囊泡。假设DRS2直接将磷脂底物泵送到整个TGN膜上,以诱导膜曲率,该膜曲率被网状蛋白捕获并成型为囊泡。提出的研究将首次确定P4-ATPase(DRS2)是否足够以纯化的形式足以直接催化蛋白质脂质体中的磷脂氟脂脂活性。天然底物偏好将在重构系统中确定,以及非催化亚基(CDC50)对Flippase活性的贡献。将测试DRS2活性对膜曲率和囊泡形成与蛋白脂质体和分离的TGN膜的影响。此外,初步研究表明,DRS2是控制TGN(磷脂酰肌醇4-磷酸,ARFGEF,KES1)的重要分子的新型效应子,并且将确定该调节的机械基础。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of a Golgi flippase by phosphoinositides and an ArfGEF.
- DOI:10.1038/ncb1989
- 发表时间:2009-12
- 期刊:
- 影响因子:21.3
- 作者:Natarajan, Paramasivam;Liu, Ke;Patil, Dustin V.;Sciorra, Vicki A.;Jackson, Catherine L.;Graham, Todd R.
- 通讯作者:Graham, Todd R.
Interplay of proteins and lipids in generating membrane curvature.
- DOI:10.1016/j.ceb.2010.05.002
- 发表时间:2010-08
- 期刊:
- 影响因子:7.5
- 作者:Graham TR;Kozlov MM
- 通讯作者:Kozlov MM
Phospholipid flippases: building asymmetric membranes and transport vesicles.
- DOI:10.1016/j.bbalip.2011.12.007
- 发表时间:2012-08
- 期刊:
- 影响因子:0
- 作者:Sebastian TT;Baldridge RD;Xu P;Graham TR
- 通讯作者:Graham TR
Dissection of Swa2p/auxilin domain requirements for cochaperoning Hsp70 clathrin-uncoating activity in vivo.
剖析体内共陪伴 Hsp70 网格蛋白脱壳活性的 Swa2p/auxilin 结构域要求。
- DOI:10.1091/mbc.e06-02-0106
- 发表时间:2006
- 期刊:
- 影响因子:3.3
- 作者:Xiao,Jing;Kim,LeslieS;Graham,ToddR
- 通讯作者:Graham,ToddR
共 4 条
- 1
TODD R GRAHAM的其他基金
Mechanisms of membrane homeostasis through protein and lipid transport
通过蛋白质和脂质运输实现膜稳态的机制
- 批准号:1054402510544025
- 财政年份:2022
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Mechanisms of membrane homeostasis through protein and lipid transport
通过蛋白质和脂质运输实现膜稳态的机制
- 批准号:1033065410330654
- 财政年份:2022
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
P4-ATPase mechanism of phospholipid translocation
P4-ATP酶磷脂易位机制
- 批准号:87245348724534
- 财政年份:2013
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
P4-ATPase mechanism of phospholipid translocation
P4-ATP酶磷脂易位机制
- 批准号:85752048575204
- 财政年份:2013
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
- 批准号:65259856525985
- 财政年份:2001
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
- 批准号:66555306655530
- 财政年份:2001
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
- 批准号:77811067781106
- 财政年份:2001
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
- 批准号:63828106382810
- 财政年份:2001
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
- 批准号:82725618272561
- 财政年份:2001
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Drs2p Function in Clathrin-coated Vesicle Budding
Drs2p 在网格蛋白包被的囊泡出芽中的功能
- 批准号:80762848076284
- 财政年份:2001
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds
用于评估临床相关基因变异组以筛选异生化合物的肝脏芯片平台
- 批准号:1073821510738215
- 财政年份:2023
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
- 批准号:1063115610631156
- 财政年份:2022
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:1035656510356565
- 财政年份:2022
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Establishing Sox9 as a regulator of intrahepatic bile duct development and regeneration
建立 Sox9 作为肝内胆管发育和再生的调节因子
- 批准号:1053787410537874
- 财政年份:2022
- 资助金额:$ 30.81万$ 30.81万
- 项目类别:
Elucidating the role of the microbiome in inducing gut permeability and inflammation
阐明微生物组在诱导肠道通透性和炎症中的作用
- 批准号:1037014410370144
- 财政年份:2022
- 资助金额:$ 30.81万$ 30.81万
- 项目类别: